ABSTRACT
The shape and number of mitochondria respond to the metabolic needs during the cell cycle of the eukaryotic cell. In the best-studied model systems of animals and fungi, the cells contain many mitochondria, each carrying its own nucleoid. The organelles, however, mostly exist as a dynamic network, which undergoes constant cycles of division and fusion. These mitochondrial dynamics are driven by intricate protein machineries centered around dynamin-related proteins (DRPs). Here, we review recent advances on the dynamics of mitochondria and mitochondrion-related organelles (MROs) of parasitic protists. In contrast to animals and fungi, many parasitic protists from groups of Apicomplexa or Kinetoplastida carry only a single mitochondrion with a single nucleoid. In these groups, mitochondrial division is strictly coupled to the cell cycle, and the morphology of the organelle responds to the cell differentiation during the parasite life cycle. On the other hand, anaerobic parasitic protists such as Giardia, Entamoeba, and Trichomonas contain multiple MROs that have lost their organellar genomes. We discuss the function of DRPs, the occurrence of mitochondrial fusion, and mitophagy in the parasitic protists from the perspective of eukaryote evolution.
Subject(s)
Mitochondrial Dynamics , Parasites/pathogenicity , Parasitic Diseases/epidemiology , Parasitic Diseases/physiopathology , Animals , Parasitic Diseases/parasitologyABSTRACT
According to the literature review, CO2 insufflation on parasitic myoma implantation is not well studied, and we concur that our study is related to "Morcellation-induced parasitic myomas." We did not compare CO2 insufflation to non-insufflation in our study. The reason is the efficacy of gasless laparoscopic myomectomy and morcellation is not well established and this modality is seldom performed. Moreover, the effects of pneumoperitoneum on mesothelial cells and the role of the entire peritoneal cavity as a cofactor in adhesion formation have become well established, the role of CO2 insufflation in the establishment of parasitic myomas has not yet been studied. As such, more in-depth and well-designed studies for the role of CO2 insufflation are needed.
Subject(s)
Estrogens/pharmacology , Myoma/surgery , Neovascularization, Physiologic/drug effects , Uterine Neoplasms/surgery , Animals , Female , Humans , Laparoscopy/adverse effects , Mice, SCID , Morcellation/adverse effects , Myoma/parasitology , Myoma/physiopathology , Neovascularization, Physiologic/physiology , Parasitic Diseases/etiology , Parasitic Diseases/physiopathology , Transplantation, Heterologous , Uterine Neoplasms/parasitology , Uterine Neoplasms/physiopathologyABSTRACT
Despite important differences between infectious diseases and cancers, tumour development (neoplasia) can nonetheless be closely compared to infectious disease because of the similarity of their effects on the body. On this basis, we predict that many of the life-history (LH) responses observed in the context of host-parasite interactions should also be relevant in the context of cancer. Parasites are thought to affect LH traits of their hosts because of strong selective pressures like direct and indirect mortality effects favouring, for example, early maturation and reproduction. Cancer can similarly also affect LH traits by imposing direct costs and/or indirectly by triggering plastic adjustments and evolutionary responses. Here, we discuss how and why a LH focus is a potentially productive but under-exploited research direction for cancer research, by focusing our attention on similarities between infectious disease and cancer with respect to their effects on LH traits and their evolution. We raise the possibility that LH adjustments can occur in response to cancer via maternal/paternal effects and that these changes can be heritable to (adaptively) modify the LH traits of their offspring. We conclude that LH adjustments can potentially influence the transgenerational persistence of inherited oncogenic mutations in populations.
Subject(s)
Host-Parasite Interactions/physiology , Neoplasms/etiology , Parasitic Diseases/etiology , Animals , Biological Evolution , Humans , Neoplasms/pathology , Neoplasms/physiopathology , Parasitic Diseases/parasitology , Parasitic Diseases/physiopathologyABSTRACT
By definition, parasites harm their hosts, but in many infections much of the pathology is driven by the host immune response rather than through direct damage inflicted by parasites. While these immunopathological effects are often well studied and understood mechanistically in individual disease interactions, there remains relatively little understanding of their broader impact on the evolution of parasites and their hosts. Here, we theoretically investigate the implications of immunopathology, broadly defined as additional mortality associated with the host's immune response, on parasite evolution. In particular, we examine how immunopathology acting on different epidemiological traits (namely transmission, virulence and recovery) affects the evolution of disease severity. When immunopathology is costly to parasites, such that it reduces their fitness, for example by decreasing transmission, there is always selection for increased disease severity. However, we highlight a number of host-parasite interactions where the parasite may benefit from immunopathology, and highlight scenarios that may lead to the evolution of slower growing parasites and potentially reduced disease severity. Importantly, we find that conclusions on disease severity are highly dependent on how severity is measured. Finally, we discuss the effect of treatments used to combat disease symptoms caused by immunopathology.
Subject(s)
Host-Parasite Interactions , Parasites/physiology , Parasites/pathogenicity , Parasitic Diseases/immunology , Parasitic Diseases/physiopathology , Animals , Biological Evolution , Humans , Models, Biological , Parasites/immunology , Parasitic Diseases/mortality , Parasitic Diseases/parasitology , Virulence/immunologyABSTRACT
One common physiological phenomenon that is involved both in infectious and in malignant processes is the reduction in appetite: disease anorexia. An increase in plasma levels of leptin with inflammation is thought to be involved in this process. However, from an evolutionary perspective, in certain cases, it would be more adaptive for an internal parasite to stimulate the appetite of the host instead of causing its suppression. We tested whether a parasitic infection with the larvae of the helminth parasite Taenia taeniaformis affects the levels of appetite-regulating proteins, such as leptin, ghrelin and neuropeptide-Y (NPY) in wild yellow-necked mouse (Apodemus flavicollis). We found that infected mice had lower plasma levels of leptin and increased levels of NPY than the uninfected subjects. Ghrelin levels were not associated with the occurrence of the parasites; however, these levels strongly correlated with the levels of NPY. This study suggests a possible manipulation by parasitic larvae of appetite regulation in infected subjects.
Subject(s)
Leptin/blood , Leptin/physiology , Parasitic Diseases/physiopathology , Animals , Anorexia/etiology , Appetite , Appetite Regulation/physiology , Ghrelin/blood , Host-Parasite Interactions , Hunger , Male , Mice , Neuropeptide Y/blood , Parasitic Diseases/complications , TaeniaABSTRACT
As an important type of programmed cell death in addition to apoptosis, necroptosis occurs in a variety of pathophysiological processes, including infections, liver diseases, kidney injury, neurodegenerative diseases, cardiovascular diseases, and human tumors. It can be triggered by a variety of factors, such as tumor necrosis factor receptor and Tolllike receptor families, intracellular DNA and RNA sensors, and interferon, and is mainly mediated by receptorinteracting protein kinase 1 (RIP1), RIP3, and mixed lineage kinase domainlike protein. A better understanding of the mechanism of necroptosis may be useful in the development of novel drugs for necroptosisrelated diseases. In this review, the focus is on the molecular mechanisms of necroptosis, exploring the role of necroptosis in different pathologies, discussing their potential as a novel therapeutic target for disease therapy, and providing suggestions for further study in this area.
Subject(s)
Cardiovascular Diseases/genetics , Infections/genetics , Necroptosis/genetics , Neoplasms/genetics , Neurodegenerative Diseases/genetics , Apoptosis/genetics , Bacterial Infections/genetics , Bacterial Infections/physiopathology , Cardiovascular Diseases/physiopathology , Humans , Infections/physiopathology , Mycoses/genetics , Mycoses/physiopathology , Necroptosis/drug effects , Necroptosis/physiology , Neoplasms/physiopathology , Neurodegenerative Diseases/physiopathology , Parasitic Diseases/genetics , Parasitic Diseases/physiopathologyABSTRACT
Bacteria, archaeae, fungi and viruses of the intestinal microbiome play an important role as symbionts in the complex human ecosystem. Parasites, which account for about 40â% of the earth's biodiversity, depend on hosts to complete their life cycle. This article explains how they use them and which signalling pathways play a role in this, using toxoplasmosis and malaria as examples. The parasitic manipulation hypothesis is based on impressive observations in the wild and under laboratory conditions, especially in invertebrates. For the assumption of an adaptive manipulation, every step from the genotype, the translated messenger, and its source via the used signalling pathways to the altered host behaviour must be proven. The assumption of an adaptive manipulation of humans by T. gondii in the sense of a cause-effect relationship is not proven. Alternative explanations include the inflammatory and immunological processes on the host side, which change the neuronal signal transduction as concomitant symptoms of an infection. Even without confirmation of parasitic manipulation in humans, it could be worthwhile to further investigate the observed associations in order to develop new possibilities for diagnosis and therapy, e.âg. for schizophrenia.
Subject(s)
Host-Parasite Interactions , Parasitic Diseases , Signal Transduction , Animals , Behavioral Symptoms/parasitology , Behavioral Symptoms/physiopathology , Female , Humans , Malaria , Male , Parasitic Diseases/parasitology , Parasitic Diseases/physiopathology , ToxoplasmosisABSTRACT
An increasing number of critically ill patients are immunocompromised. Acute hypoxemic respiratory failure (ARF), chiefly due to pulmonary infection, is the leading reason for ICU admission. Identifying the cause of ARF increases the chances of survival, but may be extremely challenging, as the underlying disease, treatments, and infection combine to create complex clinical pictures. In addition, there may be more than one infectious agent, and the pulmonary manifestations may be related to both infectious and non-infectious insults. Clinically or microbiologically documented bacterial pneumonia accounts for one-third of cases of ARF in immunocompromised patients. Early antibiotic therapy is recommended but decreases the chances of identifying the causative organism(s) to about 50%. Viruses are the second most common cause of severe respiratory infections. Positive tests for a virus in respiratory samples do not necessarily indicate a role for the virus in the current acute illness. Invasive fungal infections (Aspergillus, Mucorales, and Pneumocystis jirovecii) account for about 15% of severe respiratory infections, whereas parasites rarely cause severe acute infections in immunocompromised patients. This review focuses on the diagnosis of severe respiratory infections in immunocompromised patients. Special attention is given to newly validated diagnostic tests designed to be used on non-invasive samples or bronchoalveolar lavage fluid and capable of increasing the likelihood of an early etiological diagnosis.
Subject(s)
Immunocompromised Host/immunology , Respiratory Tract Infections/diagnosis , Humans , Immunocompromised Host/drug effects , Intensive Care Units/organization & administration , Invasive Fungal Infections/complications , Invasive Fungal Infections/physiopathology , Parasitic Diseases/complications , Parasitic Diseases/physiopathology , Pneumonia, Bacterial/etiology , Pneumonia, Bacterial/physiopathology , Respiratory Insufficiency/etiology , Respiratory Insufficiency/physiopathology , Respiratory Tract Infections/etiology , Respiratory Tract Infections/physiopathologyABSTRACT
BACKGROUND: Sleep is a biological enigma. Despite occupying much of an animal's life, and having been scrutinized by numerous experimental studies, there is still no consensus on its function. Similarly, no hypothesis has yet explained why species have evolved such marked variation in their sleep requirements (from 3 to 20 hours a day in mammals). One intriguing but untested idea is that sleep has evolved by playing an important role in protecting animals from parasitic infection. This theory stems, in part, from clinical observations of intimate physiological links between sleep and the immune system. Here, we test this hypothesis by conducting comparative analyses of mammalian sleep, immune system parameters, and parasitism. RESULTS: We found that evolutionary increases in mammalian sleep durations are strongly associated with an enhancement of immune defences as measured by the number of immune cells circulating in peripheral blood. This appeared to be a generalized relationship that could be independently detected in 4 of the 5 immune cell types and in both of the main sleep phases. Importantly, no comparable relationships occur in related physiological systems that do not serve an immune function. Consistent with an influence of sleep on immune investment, mammalian species that sleep for longer periods also had substantially reduced levels of parasitic infection. CONCLUSION: These relationships suggest that parasite resistance has played an important role in the evolution of mammalian sleep. Species that have evolved longer sleep durations appear to be able to increase investment in their immune systems and be better protected from parasites. These results are neither predicted nor explained by conventional theories of sleep evolution, and suggest that sleep has a much wider role in disease resistance than is currently appreciated.
Subject(s)
Immunity, Innate , Mammals/physiology , Parasitic Diseases/physiopathology , Sleep , Animals , Biological Evolution , Host-Parasite Interactions , Mammals/immunology , Mammals/parasitology , Parasites , Parasitic Diseases/immunology , Parasitic Diseases/parasitologyABSTRACT
During pregnancy, the mammalian endocrine system plays a leading role in maintaining the fetus, characterized by an increase in the level of hormones such as progesterone, oestradiol and some gonadotropic hormones. The immune system participates during pregnancy by self-regulating to prevent fetus rejection. The distinctive type of immunity during gestation is characterized by an increase in levels of Th2 type cytokines IL-4, IL-6 and IL-10, concomitant with a decrease in IL-2, INF-gamma and TNF-alpha levels. Along pregnancy, sex steroids and factors associated with them regulate the immune response. In this way, endocrine and immunologic factors have an impact on the pregnant female's susceptibility or resistance to parasitic diseases. There are three main mechanisms proposed to explain this susceptibility or resistance: (1) sex steroids influence the host's immune system; (2) hormones acting directly on the parasites inhibit or promote their reproduction, or (3) the two effects can occur simultaneously within a network of immuno-endocrine host-parasite interactions, mediated by hormones, cytokines, antibodies and other factors interacting directly and bidirectionally. The present work reviews recent literature concerning the most frequent parasitic infections during pregnancy and discusses the mechanisms implied in the establishment, growth, reproduction or elimination of the parasite.
Subject(s)
Cytokines/physiology , Hormones/physiology , Host-Parasite Interactions/physiology , Parasitic Diseases/physiopathology , Pregnancy Complications, Infectious/parasitology , Animals , Antibody Formation , Disease Susceptibility , Endometrium/immunology , Female , Fetus/immunology , Gene Expression Regulation , Gonadal Steroid Hormones/physiology , Host-Parasite Interactions/immunology , Humans , Immunity, Cellular , Lymphocyte Subsets/immunology , Male , Mammals/immunology , Mammals/physiology , Models, Immunological , Parasitemia/immunology , Parasitemia/physiopathology , Parasitic Diseases/immunology , Pregnancy , Pregnancy Complications, Infectious/immunology , Pregnancy Complications, Infectious/physiopathologyABSTRACT
Ceramide has been shown to be critically involved in multiple biological processes, for instance induction of apoptosis after ligation of death receptors or application of gamma-irradiation or UV-A light, respectively, regulation of cell differentiation, control of tumor cell growth, infection of mammalian cells with pathogenic bacteria and viruses or the control of embryo and organ development to name a few examples. Ceramide molecules form distinct large domains in the cell membrane, which may serve to re-organize cellular receptors and signalling molecules. Thus, in many conditions, ceramide may be involved in the spatial and temporal organisation of specific signalling pathways explaining the pleiotrophic effects of this lipid. Here, we focus on the role of ceramide and ceramide-enriched membrane domains, respectively, in bacterial infections, in particular of the lung, and sepsis. We describe the role of ceramide for infections with Neisseriae gonorhoeae, Staphylococcus aureus and Pseudomonas aeruginosa. Finally, we discuss newly emerging aspects of the cellular function of ceramide, i.e. its role in germ line and embryo development.
Subject(s)
Bacterial Infections/physiopathology , Cell Membrane/physiology , Ceramides/physiology , Embryonic Development/physiology , Animals , Apoptosis/drug effects , Cystic Fibrosis/physiopathology , Embryo Implantation/physiology , Female , Germ Cells/growth & development , Gonorrhea/enzymology , Gonorrhea/etiology , Humans , Male , Parasitic Diseases/physiopathology , Pseudomonas Infections/etiology , Sepsis/enzymology , Sphingomyelin Phosphodiesterase/metabolism , Staphylococcal Infections/etiology , Virus Diseases/physiopathologyABSTRACT
Tolerance, or the maintenance of host health or fitness at a given parasite burden, has often been studied in evolutionary and medical contexts, particularly with respect to effects on the evolution of parasite virulence and individual patient outcomes. These bodies of work have provided insight about tolerance for evolutionary phenomena (e.g., virulence) and individual health (e.g., recovering from an infection). However, due to the specific motivations of that work, few studies have considered the ecological ramifications of variation in tolerance, namely, how variation in forms of tolerance could mediate parasite movement through populations and even community-level disease dynamics. Tolerance is most commonly regarded as the relationship between host fitness and parasite burden. However, few if any studies have actually quantified host fitness, instead utilizing proxies of fitness as the response variables to be regressed against parasite burden. Here, we address how attention to the effects of parasite burden on traits that are relevant to host competence (i.e., the ability to amplify parasites to levels transmissible to other hosts/vectors) will enhance our understanding of disease dynamics in nature. We also provide several forms of guidance for how to overcome the challenges of quantifying tolerance in wild organisms.
Subject(s)
Host-Parasite Interactions , Parasitic Diseases/transmission , Adaptation, Biological , Animals , Disease Resistance , Parasite Load , Parasites/pathogenicity , Parasites/physiology , Parasitic Diseases/parasitology , Parasitic Diseases/physiopathologyABSTRACT
Parasites have evolved various mechanisms to favor infection of their hosts and enhance the success of the infection. In this respect, time-of-day effects were found during the course of parasitic infections, which can be caused or controlled by circadian rhythms in the physiology of their vertebrate hosts. These include circadian clock-controlled rhythms in metabolism and in immune responses. Conversely, parasites can also modulate their hosts' behavioral and cellular rhythms. Lastly, parasites themselves were in some cases shown to possess their own circadian clock mechanisms, which can influence their capacity to infect their hosts. A better knowledge of the circadian regulation of host-parasite interactions will help in designing new preventive and therapeutic strategies for parasitic diseases.
Subject(s)
Circadian Clocks/physiology , Circadian Rhythm/physiology , Host-Parasite Interactions/physiology , Parasitic Diseases/immunology , Parasitic Diseases/physiopathology , Animals , Botrytis/physiology , Cell Physiological Phenomena/physiology , Helminths/physiology , Humans , Leishmania/physiology , Mice , Plasmodium/physiology , Trypanosoma/physiologyABSTRACT
We investigated the impact of helminths and malaria infection on Kaposi's sarcoma associated herpesvirus (KSHV) seropositivity, using samples and data collected from a cluster-randomised trial of intensive versus standard anthelminthic treatment. The trial was carried out in 2012 to 2016 among fishing communities on Lake Victoria islands in Uganda. Plasma samples from 2881 participants from two household surveys, the baseline (1310 participants) and the final (1571 participants) surveys were tested for KSHV IgG antibody responses to K8.1 and ORF73 recombinant proteins using ELISA. The baseline survey was carried out before the trial intervention while the final survey was carried out after three years of the trial intervention. Additionally, a subset sample of 372 participants from the final survey was tested for IgE, IgG and IgG4 antibody concentrations to S. mansoni adults worm antigen (SWA) and S. mansoni egg antigen (SEA) using ELISA. Infection by helminths (S. mansoni, N. americanus, T. trichiura and S. stercoralis) was diagnosed using real-time PCR, urine circulating cathodic antigen (CCA) and stool microscopy (Kato-Katz method) while malaria infection was diagnosed using microscopy. We analysed the relationship between helminth and malaria infections and KSHV seropositivity using regression modelling, allowing for survey design. At baseline, 56% of the participants were male while 48% of the participants were male in the final survey. The most prevalent helminth infection was S. mansoni (at baseline 52% and 34% in the final survey by microscopy, 86% by CCA and 50% by PCR in the final survey). KSHV seropositivity was 66% (baseline) and 56% (final survey) among those 1-12 years and >80% in those 13+ years in both surveys; malaria parasitaemia prevalence was 7% (baseline) and 4% (final survey). At baseline, individuals infected with S. mansoni (detected by microscopy) were more likely to be KSHV seropositive (aOR = 1.86 (1.16, 2.99) p = 0.012) and had higher anti-K8.1 antibody levels (acoefficient = 0.03 (0.01, 0.06) p = 0.02). In the final survey, S. mansoni (by microscopy, adjusted Odds Ratio (aOR = 1.43 (1.04-1.95), p = 0.028) and malaria parasitaemia (aOR = 3.49 (1.08-11.28), p = 0.038) were positively associated with KSHV seropositivity. Additionally, KSHV seropositive participants had higher S. mansoni-specific IgE and IgG antibody concentrations in plasma. Furthermore, HIV infected individuals on cART were less likely to be KSHV seropositive compared to HIV negative individuals (aOR = 0.46 (0.30, 0.71) p = 0.002). Schistosoma species skew the immune response towards Th2 and regulatory responses, which could impact on KSHV reactivation if co-infected with both organisms.
Subject(s)
Antigens, Helminth/immunology , Herpesvirus 8, Human/immunology , Parasitic Diseases/epidemiology , Parasitic Diseases/immunology , Adolescent , Adult , Aged , Albendazole/therapeutic use , Animals , Antibodies, Helminth/blood , Child , Child, Preschool , Cross-Sectional Studies , HIV Infections/immunology , Helminthiasis/drug therapy , Helminthiasis/epidemiology , Helminthiasis/immunology , Helminthiasis/parasitology , Humans , Immunoglobulin E/blood , Immunoglobulin G/blood , Infant , Islands , Lakes , Malaria/immunology , Middle Aged , Odds Ratio , Parasitic Diseases/drug therapy , Parasitic Diseases/physiopathology , Praziquantel/therapeutic use , Prevalence , Schistosoma mansoni/immunology , Schistosomiasis mansoni/epidemiology , Uganda/epidemiology , Young AdultABSTRACT
Lymphatic disease is quite prevalent, and often not well clinically characterized. Beyond lymphedema, there is a broad array of human disease that directly or indirectly alters lymphatic structure and function. The symptomatic and objective presentation of these patients can be quite diverse. In this review, we have attempted to provide a systematic overview of the subjective and objective spectrum of lymphatic disease, with consideration of all of the categories of disease that primarily or secondarily impair the functional integrity of the lymphatic system. Lymphedema is discussed, along with chromosomal disorders, lymphangioma, infectious diseases, lymphangioleiomyomatosis, lipedema, heritable genetic disorders, complex vascular malformations, protein-losing enteropathy, and intestinal lymphangiectasia.
Subject(s)
Lymphatic Diseases/pathology , Lymphatic Diseases/physiopathology , Chromosome Disorders , Communicable Diseases/pathology , Communicable Diseases/physiopathology , Humans , Lymphangioleiomyomatosis/complications , Lymphangioleiomyomatosis/pathology , Lymphangioleiomyomatosis/physiopathology , Lymphangioma/pathology , Lymphangioma/physiopathology , Lymphatic Diseases/complications , Lymphatic Diseases/diagnosis , Lymphedema/genetics , Lymphedema/pathology , Lymphedema/physiopathology , Parasitic Diseases/complications , Parasitic Diseases/pathology , Parasitic Diseases/physiopathology , Protein-Losing Enteropathies/complications , Protein-Losing Enteropathies/pathology , Protein-Losing Enteropathies/physiopathology , Subcutaneous Fat/pathologyABSTRACT
Galectins is a family of multifunctional lectins. Fifteen galectins have been identified from a variety of cells and tissues of vertebrates and invertebrates. Galectins have been shown to play pivotal roles in host-pathogen interaction such as adhesion of pathogens to host cells and activation of host innate and adaptive immunity. In recent years, the roles of galectins during parasite infections have gained increasing attention. Galectins produced by different hosts can act as pattern recognition receptors detecting conserved pathogen-associated molecular patterns of parasites, while galectins produced by parasites can modulate host responses. This review summarizes some recent studies on the roles of galectins produced by parasitic protozoa, nematodes, and trematodes and their hosts. Understanding the roles of galectins in host-parasite interactions may provide targets for immune intervention and therapies of parasitic infections.
Subject(s)
Galectins/physiology , Host-Parasite Interactions/physiology , Immunity, Innate/physiology , Nematode Infections/physiopathology , Parasitic Diseases/physiopathology , Protozoan Infections/physiopathology , Trematode Infections/physiopathology , Animals , HumansABSTRACT
The Ixodes tick is an important arthropod vector in the transmission of human disease. This 3-part review highlights the biology of the Ixodes tick and manifestations of related diseases. Part 1 addresses the Ixodes tick biology and life cycle; local reactions; and Lyme disease, the most prevalent of associated diseases. Part 2 will address human granulocytic anaplasmosis, babesiosis, Powassan virus infection, Borrelia miyamotoi disease, tick-borne encephalitis, and tick paralysis. Part 3 will address coinfection with multiple pathogens as well as methods of tick-bite prevention and tick removal.
Subject(s)
Babesiosis/physiopathology , Ixodes/physiology , Lyme Disease/physiopathology , Skin Diseases, Infectious/physiopathology , Tick Infestations/physiopathology , Animals , Babesiosis/parasitology , Babesiosis/therapy , Humans , Ixodes/growth & development , Ixodes/parasitology , Life Cycle Stages , Lyme Disease/parasitology , Lyme Disease/therapy , Parasitic Diseases/parasitology , Parasitic Diseases/physiopathology , Parasitic Diseases/therapy , Tick Bites/physiopathology , Tick Bites/therapy , Tick Infestations/therapyABSTRACT
In April 2004, an outbreak of acute diarrheal illness occurred among the Orang Asli (aborigine) in the Cameron Highlands, Pahang State, Peninsular Malaysia, where rotavirus was later implicated as the cause. In the course of the epidemic investigation, stool samples were collected and examined for infectious agents including parasites. Soil transmitted helminthes (STH), namely Ascaris lumbricoides (25.7%), Trichuris trichiura (31.1%) and hookworm (8.1%), and intestinal protozoa, which included Giardia lamblia (17.6%), Entamoeba histolytica/E. dispar (9.4%), Blastocystis hominis (8.1%) and Cryptosporidium parvum (2.7%), were detected. Forty-four (59.5%) were infected with at least one parasite, 24 (32.4%), 12 (16.2%) and 8 (10.8%) had single, double and triple parasitic infections, respectively. STH were prevalent with infections occurring as early as in infancy. Giardia lamblia, though the most commonly found parasite in samples from symptomatic subjects, was within the normally reported rate of giardiasis among the various communities in Malaysia, and was an unlikely cause of the outbreak. However, heavy pre-existing parasitic infections could have contributed to the severity of the rotavirus diarrheal outbreak.
Subject(s)
Parasitic Diseases/epidemiology , Population Groups , Adolescent , Adult , Animals , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Malaysia/epidemiology , Parasitic Diseases/physiopathology , Population Surveillance/methodsABSTRACT
This article discusses the contribution made by non-viral infections to the global burden of cancer and describes the bacterial, protozoan and fungal organisms that are believed to cause cancer, either directly or indirectly.
Subject(s)
Bacterial Infections/complications , Neoplasms/microbiology , Neoplasms/parasitology , Parasitic Diseases/complications , Aspergillosis/complications , Aspergillosis/physiopathology , Bacterial Infections/physiopathology , Humans , Neoplasms/physiopathology , Parasitic Diseases/physiopathologyABSTRACT
This paper analyzes a prey-predator system in which some members of the prey population and all predators are subjected to infection by a parasite. The predator functional response is a function of a weighted sum of prey abundances. Persistence and extinction criteria are derived. The stability of the interior equilibrium point is discussed. The role of delay is also addressed. Lastly the results are verified through computer simulation. Numerical simulation suggests that the delay has a destabilizing effect.